Evidence map›Paper›PMID 18626010›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2008

Deficiency of Aph1B/C-gamma-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment.

T Dejaegere, L Serneels, M K Schäfer, J Van Biervliet, K Horré, C Depboylu, D Alvarez-Fischer, A Herreman, M Willem, C Haass and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Selective inhibitors of the PSEN1-gamma-secretase complex.The Journal of biological chemistry · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Nrg1 Intracellular Signaling Is Neuroprotective upon Stroke.Oxidative medicine and cellular longevity · 2019
    Article
  11. Article
  12. Neuregulin 3 and its roles in schizophrenia risk and presentation.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

T DejaegereDepartment of Molecular and Developmental Genetics, Vlaams Instituut voor Biotechnologie, 3000 Leuven, Belgium.
L Serneels
M K Schäfer
J Van Biervliet
K Horré
C Depboylu
D Alvarez-Fischer
A Herreman
M Willem
C Haass
G U Höglinger
R D'Hooge
B De Strooper
Center for Human Genetics · USPhilipps University of Marburg · DELudwig-Maximilians-Universität München · DEVlaams Instituut voor Biotechnologie · BEKU Leuven · BENeuroscience Institute · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Regulated intramembrane proteolysis by gamma-secretase cleaves proteins in their transmembrane domain and is involved in important signaling pathways. At least four different gamma-secretase complexes have been identified, but little is known about their biological role and specificity. Previous work has demonstrated the involvement of the Aph1A-gamma-secretase complex in Notch signaling, but no specific function could be assigned to Aph1B/C-gamma-secretase. We demonstrate here that the Aph1B/C-gamma-secretase complex is expressed in brain areas relevant to schizophrenia pathogenesis and that Aph1B/C deficiency causes pharmacological and behavioral abnormalities that can be reversed by antipsychotic drugs. At the molecular level we find accumulation of Nrg1 fragments in the brain of Aph1BC(-/-) mice. Our observations gain clinical relevance by the demonstration that a Val-to-Leu mutation in the Nrg1 transmembrane domain, associated with increased risk for schizophrenia, affects gamma-secretase cleavage of Nrg1. This finding suggests that dysregulation of intramembrane proteolysis of Nrg1 could increase risk for schizophrenia and related disorders.

Indexed as

Amyloid Precursor Protein SecretasesAnimalsAntipsychotic AgentsEndopeptidasesGait Disorders, NeurologicMembrane ProteinsMiceMice, KnockoutMutation, MissenseNeuregulin-1Protein SubunitsSchizophreniaAmyloid Precursor Protein SecretasesAntipsychotic AgentsAph1b protein, mouseAph1C protein, mouseEndopeptidasesMembrane ProteinsNeuregulin-1Protein Subunits

Identifiers

PMID18626010
PMCPMC2474502
OpenAlexW2019007281

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.